Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

200 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Completed

Phase I Platinum Based Chemotherapy Plus Indomethacin

NCT01719926

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +24 more
Locations
  • the Netherlands Cancer Institute Amsterdam, Netherlands
  • Meander Medisch Centrum Amersfoort, Utrecht, Netherlands
  • UMC Utrecht Utrecht, Netherlands
  • Oncology Institute of Southern Switzerland Bellinzona, Switzerland
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NCT03326193

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Anchorage, Alaska, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Burbank, California, United States
View all 29 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer

NCT03574779

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Stanford, California, United States
View all 28 locations
View Trial Details
Completed

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT01932125

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Manipal Hospital Bangalore, Karnataka, India
  • HealthCare Global Enterprises Limited Banglore, Karnataka, India
  • Marthwada Regional Cancer Center & Research Institute Aurangabad, Maharashtra, India
  • MOC Cancer Care & Research Centre Mumbai, Maharashtra, India
View all 13 locations
View Trial Details

Related conditions